清池资本是一家总部位于中国香港的专注于医疗医药领域的投资平台，以投资亚洲(尤其是大中华地区)二级市场股票及私募股权中后期项目为主。(Lake Bleu Capital is a Hong Kong-based investment platform that specializes in healthcare in Asia/Greater China. With a long-term investment horizon, we manage strategies through both public and private equity with a primary focus on mid- to late-stage investments.)
Investment Stage: Series B; Series C; Series D; Series E; Series F; Series G; Series H; Private Equity
Portfolio 40
| Date | Name | Website | Total Raised | Location |
| 04.12.2022 | BangBang R... | bangbangrobotics.com | - | - |
| 11.11.2021 | Singleron | singleronbio.com | $100M | China, Jia... |
| 04.09.2020 | I-Mab Biop... | i-mabbiopharma.com | $678M | United Sta... |
| - | Kangji Med... | hzkangji.com | - | China |
| - | Lupeng Pha... | lupengbio.com | - | - |
| - | Duoning Bi... | duoningbio.com | - | - |
| - | Tigermed | tigermedgrp.com | - | - |
| - | Joinn Lab | joinn-lab.com | - | - |
| - | Brii Biosc... | briibio.com | $415M | China |
| - | Alphamab O... | alphamab.com | - | - |
Show more
Persons 13
| Date | First Name | Last Name | Title | Location | |||
| - | Nicoletta | Chau | Finance an... | linkedin.c... | - | n*********... | - |
| - | Lucia | Qian, ACCA | Parnter | linkedin.c... | - | l********n... | - |
| - | Ran | Huo | Executive ... | linkedin.c... | - | r*****o@la... | - |
| - | Amanda Hai... | Li | Executive ... | linkedin.c... | - | a*******i@... | - |
| - | Tse | Grace | Assistant ... | linkedin.c... | - | g*******e@... | - |
| - | Celine | Zhu 祝纯 | Investor R... | linkedin.c... | - | c********u... | - |
| - | Samson | Chan | Finance an... | linkedin.c... | - | i**o@lakeb... | - |
| - | Bin | Li | Founding P... | linkedin.c... | - | b****i@lak... | - |
| - | Michael | Sun | Partner &a... | linkedin.c... | - | m*********... | - |
| - | Annie (Lia... | Jin, CFA | Associate | linkedin.c... | - | a*******n@... | - |
Show more
Mentions in press and media 1
| Date | Title | Description |
| 30.03.2021 | AffaMed Therapeutics : Announces Completion of over US$170 Million Series B Financing Led by Lake Bleu Capital to Further Development of Ophthalmic and Neuroscience Pipeline | SHANGHAI, March 30, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage biopharmaceutical company dedicated to addressing critical unmet patient need in ophthalmic, neurological and psychiatric disorders... |